Non-invasive biomarkers specifically targeting the dynamics of liver fibrosis, provide a novel tool to determine patient trajectories. Our collaborators use Nordic biomarkers to risk-stratify patients, and for prognostic enrichment in clinical trials targeting high-need and at-risk patients increasing the likelihood of success. Furthermore, our biomarkers are direct measurements of liver fibrosis dynamics that are currently be used to determine treatment efficacy.

More about biomarkers for NASH

Find publications

Diagnosis and prediction of disease progression in Alcoholic Liver Disease (ALD), particularly for cirrhosis, has proven difficult. Our diagnostic and prognostic biomarkers have the potential to greatly benefit patients by aiding in early diagnosis of disease and directing the most appropriate treatment at the right time. 

More about our biomarkers for Alcoholic Liver Disease

Find publications

There is an urgent need for novel biomarkers that can be used to adequately determine the risk of disease progression, as well as early treatment response. Fibrosis is a key histological feature of immune-mediated liver diseases; however, the severity of liver fibrosis is primarily assessed through the use of a liver biopsy. Our biomarkers are currently used in various ongoing clinical studies to pick out fast progressors as well as monitoring of treatment efficacy. 


More about our biomarkers for PSC and PBC

Find publications

In viral liver disease, there is a net formation (build up) of scar tissue in the tissue. The balance between degradation and formation of tissue is interrupted. Protein fingerprint biomarkers can quantify tissue turnover directly in serum or plasma samples.  

More about our biomarkers for Viral Liver Disease

Find publications

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information to provide the best possible experience. By using our website, you agree to our Privacy Policy and our cookies usage. Cookie Policy Privacy Statement